133 related articles for article (PubMed ID: 33856274)
21. Clinical features of testicular lymphoma.
Shih HJ; Shih LY; Chang H; Wang PN; Wu JH; Kuo MC; Hung YS; Dunn P
Acta Haematol; 2014; 131(3):187-92. PubMed ID: 24247653
[TBL] [Abstract][Full Text] [Related]
22. [Primary testicular lymphoma].
Motyčková M; Vosáhlová V; Belada D; Šimkovič M; Žák P
Vnitr Lek; 2017; 63(6):415-422. PubMed ID: 28840738
[TBL] [Abstract][Full Text] [Related]
23. Primary testicular lymphoma and AIDS.
Verma N; Chaudhary UB; Costa LJ; Gudena V; Lazarchick J
Ann Clin Lab Sci; 2010; 40(1):75-9. PubMed ID: 20124334
[TBL] [Abstract][Full Text] [Related]
24. Mantle cell lymphoma and diffuse large B-cell lymphoma of the testis: a unique case of composite non-Hodgkin lymphoma.
Andhavarapu S; Crozier JA; Jiang L; Sher T
Eur J Haematol; 2014 Dec; 93(6):537-42. PubMed ID: 24750331
[TBL] [Abstract][Full Text] [Related]
25. Direct Costs Associated with Relapsed Diffuse Large B-Cell Lymphoma Therapies.
Purdum A; Tieu R; Reddy SR; Broder MS
Oncologist; 2019 Sep; 24(9):1229-1236. PubMed ID: 30850561
[TBL] [Abstract][Full Text] [Related]
26. Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma.
Deutsch AJ; Steinbauer E; Hofmann NA; Strunk D; Gerlza T; Beham-Schmid C; Schaider H; Neumeister P
Mod Pathol; 2013 Feb; 26(2):182-94. PubMed ID: 22936065
[TBL] [Abstract][Full Text] [Related]
27. Role of prophylactic radiotherapy in Chinese patients with primary testicular diffuse large B-cell lymphoma: a single retrospective study.
Xu J; Ke Y; Zhang Y; Chen C; Li J; Wei Z; Liu P
J BUON; 2019; 24(2):754-762. PubMed ID: 31128033
[TBL] [Abstract][Full Text] [Related]
28. Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with
Uryu H; Mishima Y; Tsuyama N; Yokoyama M; Nishimura N; Fukuta T; Shirouchi Y; Okabe T; Inoue N; Takeuchi K; Terui Y
Leuk Lymphoma; 2021 Sep; 62(9):2141-2150. PubMed ID: 33749498
[TBL] [Abstract][Full Text] [Related]
29. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
30. Cd20 Expression and Effects on Outcome of Relapsed/ Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab.
Rasheed AA; Samad A; Raheem A; Hirani SI; Shabbir- Moosajee M
Asian Pac J Cancer Prev; 2018 Feb; 19(2):331-335. PubMed ID: 29479962
[TBL] [Abstract][Full Text] [Related]
31. Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.
King RL; Goodlad JR; Calaminici M; Dotlic S; Montes-Moreno S; Oschlies I; Ponzoni M; Traverse-Glehen A; Ott G; Ferry JA
Virchows Arch; 2020 May; 476(5):647-665. PubMed ID: 31863183
[TBL] [Abstract][Full Text] [Related]
32. [Clinical characteristics of 46 pediatric diffuse large B-cell lymphoma and treatment outcome].
Huang S; Yang J; Jin L; Duan YL; Zhang M; Zhang NN; Li Q; Zhang N; Zhou CJ; Zhang YH
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):774-779. PubMed ID: 31594064
[No Abstract] [Full Text] [Related]
33. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
34. Primary testicular diffuse large B-cell lymphoma: Case series.
Wang Q; Zheng D; Chai D; Wu S; Wang X; Chen S; Wu L; Cao R; Tao Y
Medicine (Baltimore); 2020 Mar; 99(12):e19463. PubMed ID: 32195944
[TBL] [Abstract][Full Text] [Related]
35. Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).
Bruno Ventre M; Ferreri AJ; Gospodarowicz M; Govi S; Messina C; Porter D; Radford J; Heo DS; Park Y; Martinelli G; Taylor E; Lucraft H; Hong A; Scarfò L; Zucca E; Christie D;
Oncologist; 2014 Mar; 19(3):291-8. PubMed ID: 24567283
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.
Panizo C; Rodríguez AJ; Gutiérrez G; Díaz FJ; González-Barca E; de Oña R; Grande C; Sancho JM; García-Álvarez MF; Sánchez-González B; Peñalver FJ; Cannata J; Espeso M; Requena MJ; Gardella S; Durán S; González AP; Alfonso A; Caballero MD;
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):398-403. PubMed ID: 25843416
[TBL] [Abstract][Full Text] [Related]
37. Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse.
Oka S; Ono K; Nohgawa M
Pathol Oncol Res; 2020 Jul; 26(3):1843-1850. PubMed ID: 31768966
[TBL] [Abstract][Full Text] [Related]
38. Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma.
Robertus JL; Harms G; Blokzijl T; Booman M; de Jong D; van Imhoff G; Rosati S; Schuuring E; Kluin P; van den Berg A
Mod Pathol; 2009 Apr; 22(4):547-55. PubMed ID: 19287466
[TBL] [Abstract][Full Text] [Related]
39. [Ibrutinib inhibits mesenchymal stem cells-mediated drug resistance in diffuse large B-cell lymphoma].
Wu L; Zhang YZ; Xia B; Li XW; Yuan T; Tian C; Zhao HF; Yu Y; Sotomayor E
Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1036-1042. PubMed ID: 29365396
[No Abstract] [Full Text] [Related]
40. [Diffuse large B-cell lymphoma of the testis relapsed 16 years after achieving complete response].
Nagasaka I; Mitsui T; Ishizaki T; Koiso H; Yokohama A; Saitoh T; Hirato J; Igarashi T; Kojima M; Tsukamoto N; Nojima Y; Murakami H; Handa H
Rinsho Ketsueki; 2015 Dec; 56(12):2447-51. PubMed ID: 26725353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
